Webinars

As science and technology evolve, diagnosis of complex diseases and therapeutic decisions are based on the biological characteristics of each individual patient. The use of molecular diagnostics and specific biomarkers enables quicker selection of the right therapy for the right patient, reducing reliance on the traditional trial-and-error approach and improving therapeutic outcomes. Finally, less invasive […]

The rapidly evolving field of cell and gene therapy (CGT) presents unique scientific and operational challenges, alongside increasingly rigorous regulatory expectations. This webinar provides a structured overview of the current global regulatory landscape, highlighting key guidance from the FDA, EMA, and Health Canada, and outlining how these expectations differ from those applied to traditional pharmaceuticals. […]